Aflibercept for metastatic colorectal cancer: safety data from the Spanish named patient program

M Salgado Fernandez, MT Perez Hoyos… - Expert Opinion on …, 2015 - Taylor & Francis
Objective: Aflibercept increased overall survival with acceptable tolerability in metastatic
colorectal cancer (mCRC) when it was used in combination with FOLFIRI after progression …
被引用次数：9 相关文章

Aflibercept for metastatic colorectal cancer: safety data from the Spanish named patient program.

PH MT, I Díaz de Corcuera - Expert Opinion on Drug Safety, 2015 - europepmc.org
Objective Aflibercept increased overall survival with acceptable tolerability in metastatic
colorectal cancer (mCRC) when it was used in combination with FOLFIRI after progression …

Aflibercept for metastatic colorectal cancer: safety data from the Spanish named patient program

MS Fernández, MTP Hoyos… - Expert opinion on …, 2015 - pubmed.ncbi.nlm.nih.gov
Objective Aflibercept increased overall survival with acceptable tolerability in metastatic
colorectal cancer (mCRC) when it was used in combination with FOLFIRI after progression …